Proteomics Market Size, Share, and Analysis, By Product (Instrumentation Technologies, Reagents & Consumables, and Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, and Others), By End User (Pharmaceutical & Biotechnology Companies, Research & Clinical Laboratories, Hospitals, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
Proteomics Market Size, Share, and Analysis, By Product (Instrumentation Technologies, Reagents & Consumables, and Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, and Others), By End User (Pharmaceutical & Biotechnology Companies, Research & Clinical Laboratories, Hospitals, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
PRODUCT OVERVIEW
Proteomics Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 14.1% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 33.2 billion and is projected to reach USD 142.7 billion by the completion of 2034.
Proteomics is the broad study of proteins, including their functions and structures. Its goal is to comprehend an organism, along with tissue or the full protein complement of the cell under certain conditions. Proteomics uses mass spectrometry and chromatography techniques to identify and measure proteins and study their functions in numerous biological processes. Unlike genomics, which focuses on DNA, proteomics emphasizes on the dynamic aspects of biological operations as proteins are the major carriers of genetic instructions. Besides, this field is important for understanding the cause of disease and designing personalized therapeutics in medicine and biotechnology.
MARKET HIGHLIGHTS
Proteomics Market is projected to reach USD 142.7 billion over the forecast period, due to technological innovations and its growing usage in drug discovery and personalized medicine. The growth is attributed to developments in high-resolution mass spectrometry and protein analysis tools, which improve the accuracy of protein characterization. In addition, the focus on understanding complex biological processes and the need for new treatment targets are also boosting market demand. Businesses are investing in creative solutions and combining proteomics with other omics technologies to provide a better understanding of biological systems. Thus, the proteomics market provides a variety of products and services such as reagents and software to meet different research and clinical requirements.
Proteomics Market Segments:
Growth Drivers
Technological Expansions is Driving Growth in the Proteomics Market
Rising Demand for Personalized Medicine Act as a Catalyst for Market Growth
Restraint
High Initial Costs in the Market Will Impact the Growth
Key Players
PRODUCT OVERVIEW
Proteomics Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 14.1% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 33.2 billion and is projected to reach USD 142.7 billion by the completion of 2034.
Proteomics is the broad study of proteins, including their functions and structures. Its goal is to comprehend an organism, along with tissue or the full protein complement of the cell under certain conditions. Proteomics uses mass spectrometry and chromatography techniques to identify and measure proteins and study their functions in numerous biological processes. Unlike genomics, which focuses on DNA, proteomics emphasizes on the dynamic aspects of biological operations as proteins are the major carriers of genetic instructions. Besides, this field is important for understanding the cause of disease and designing personalized therapeutics in medicine and biotechnology.
MARKET HIGHLIGHTS
Proteomics Market is projected to reach USD 142.7 billion over the forecast period, due to technological innovations and its growing usage in drug discovery and personalized medicine. The growth is attributed to developments in high-resolution mass spectrometry and protein analysis tools, which improve the accuracy of protein characterization. In addition, the focus on understanding complex biological processes and the need for new treatment targets are also boosting market demand. Businesses are investing in creative solutions and combining proteomics with other omics technologies to provide a better understanding of biological systems. Thus, the proteomics market provides a variety of products and services such as reagents and software to meet different research and clinical requirements.
Proteomics Market Segments:
- By Product
- Instrumentation Technologies
- Reagents & Consumables
- Software & Services
- By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Others
- By End User
- Pharmaceutical & Biotechnology Companies
- Research & Clinical Laboratories
- Hospitals
- Others
Growth Drivers
Technological Expansions is Driving Growth in the Proteomics Market
Rising Demand for Personalized Medicine Act as a Catalyst for Market Growth
Restraint
High Initial Costs in the Market Will Impact the Growth
Key Players
- Thermo Fisher Scientific
- Agilent Technologies
- Bio-Rad Laboratories
- Bruker Corporation
- AB Sciex
- GE Healthcare
- PerkinElmer
- Waters Corporation
- SABiosciences (Qiagen)
- Cell Signaling Technology
- Invitrogen
- Proteome Sciences
- Molecular Devices
- Illumina
- NanoString Technologies
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1.Regional Market Share
1.2. Business Trends
1.3.Proteomics Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Proteomics Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. PROTEOMICS MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1. Porter's Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. PROTEOMICS MARKET
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.PROTEOMICS MARKET SIZE & FORECAST 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product
11.3.1.1. Instrumentation Technologies
11.3.1.1.1. By Value (USD Million) 2024-2034F
11.3.1.1.2.Market Share (%) 2024-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.2.Reagents & Consumables
11.3.1.2.1.By Value (USD Million) 2024-2034F
11.3.1.2.2. Market Share (%) 2024-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.3.Software & Services
11.3.1.3.1.By Value (USD Million) 2024-2034F
11.3.1.3.2. Market Share (%) 2024-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2. By Application
11.3.2.1.Clinical Diagnostics
11.3.2.1.1.By Value (USD Million) 2024-2034F
11.3.2.1.2. Market Share (%) 2024-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Drug Discovery and Development
11.3.2.2.1. By Value (USD Million) 2024-2034F
11.3.2.2.2.Market Share (%) 2024-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2024-2034F
11.3.2.3.2.Market Share (%) 2024-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.3. By End User
11.3.3.1.Pharmaceutical & Biotechnology Companies
11.3.3.1.1.By Value (USD Million) 2024-2034F
11.3.3.1.2. Market Share (%) 2024-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Research & Clinical Labs
11.3.3.2.1. By Value (USD Million) 2024-2034F
11.3.3.2.2.Market Share (%) 2024-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Hospitals
11.3.3.3.1. By Value (USD Million) 2024-2034F
11.3.3.3.2.Market Share (%) 2024-2034F
11.3.3.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.4. Others
11.3.3.4.1. By Value (USD Million) 2024-2034F
11.3.3.4.2. Market Share (%) 2024-2034F
11.3.3.4.3. Y-o-Y Growth (%) 2024-2034F
12. NORTH AMERICA PROTEOMICS MARKET SIZE & FORECAST 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2.By Application
12.3.3.By End User
12.4. Country
12.4.1.United States
12.4.2. Canada
13. EUROPE PROTEOMICS MARKET SIZE & FORECAST 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product
13.3.2.By Application
13.3.3.By End User
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. ASIA-PACIFIC PROTEOMICS MARKET SIZE & FORECAST 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product
14.3.2.By Application
14.3.3.By End User
14.4. Country
14.4.1. India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. MIDDLE EAST AND AFRICA PROTEOMICS MARKET SIZE & FORECAST 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product
15.3.2.By Application
15.3.3.By End User
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4.South Africa
15.4.5. Rest of Middle East and Africa
16. LATIN AMERICA PROTEOMICS MARKET SIZE & FORECAST 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product
16.3.2.By Application
16.3.3.By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1.Thermo Fisher Scientific
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2.Agilent Technologies
18.3.Bio-Rad Laboratories
18.4.Bruker Corporation
18.5.GE Healthcare
18.6.AB Sciex
18.7.PerkinElmer
18.8.Waters Corporation
18.9.SABiosciences (Qiagen)
18.10.Cell Signaling Technology
18.11. Invitrogen
18.12.Proteome Sciences
18.13.Molecular Devices
18.14.Illumina
18.15.NanoString Technologies
18.16.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
1.1.Regional Market Share
1.2. Business Trends
1.3.Proteomics Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Proteomics Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. PROTEOMICS MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1. Porter's Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. PROTEOMICS MARKET
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.PROTEOMICS MARKET SIZE & FORECAST 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product
11.3.1.1. Instrumentation Technologies
11.3.1.1.1. By Value (USD Million) 2024-2034F
11.3.1.1.2.Market Share (%) 2024-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.2.Reagents & Consumables
11.3.1.2.1.By Value (USD Million) 2024-2034F
11.3.1.2.2. Market Share (%) 2024-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.3.Software & Services
11.3.1.3.1.By Value (USD Million) 2024-2034F
11.3.1.3.2. Market Share (%) 2024-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2. By Application
11.3.2.1.Clinical Diagnostics
11.3.2.1.1.By Value (USD Million) 2024-2034F
11.3.2.1.2. Market Share (%) 2024-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Drug Discovery and Development
11.3.2.2.1. By Value (USD Million) 2024-2034F
11.3.2.2.2.Market Share (%) 2024-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2024-2034F
11.3.2.3.2.Market Share (%) 2024-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.3. By End User
11.3.3.1.Pharmaceutical & Biotechnology Companies
11.3.3.1.1.By Value (USD Million) 2024-2034F
11.3.3.1.2. Market Share (%) 2024-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Research & Clinical Labs
11.3.3.2.1. By Value (USD Million) 2024-2034F
11.3.3.2.2.Market Share (%) 2024-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Hospitals
11.3.3.3.1. By Value (USD Million) 2024-2034F
11.3.3.3.2.Market Share (%) 2024-2034F
11.3.3.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.4. Others
11.3.3.4.1. By Value (USD Million) 2024-2034F
11.3.3.4.2. Market Share (%) 2024-2034F
11.3.3.4.3. Y-o-Y Growth (%) 2024-2034F
12. NORTH AMERICA PROTEOMICS MARKET SIZE & FORECAST 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2.By Application
12.3.3.By End User
12.4. Country
12.4.1.United States
12.4.2. Canada
13. EUROPE PROTEOMICS MARKET SIZE & FORECAST 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product
13.3.2.By Application
13.3.3.By End User
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. ASIA-PACIFIC PROTEOMICS MARKET SIZE & FORECAST 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product
14.3.2.By Application
14.3.3.By End User
14.4. Country
14.4.1. India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. MIDDLE EAST AND AFRICA PROTEOMICS MARKET SIZE & FORECAST 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product
15.3.2.By Application
15.3.3.By End User
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4.South Africa
15.4.5. Rest of Middle East and Africa
16. LATIN AMERICA PROTEOMICS MARKET SIZE & FORECAST 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product
16.3.2.By Application
16.3.3.By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1.Thermo Fisher Scientific
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2.Agilent Technologies
18.3.Bio-Rad Laboratories
18.4.Bruker Corporation
18.5.GE Healthcare
18.6.AB Sciex
18.7.PerkinElmer
18.8.Waters Corporation
18.9.SABiosciences (Qiagen)
18.10.Cell Signaling Technology
18.11. Invitrogen
18.12.Proteome Sciences
18.13.Molecular Devices
18.14.Illumina
18.15.NanoString Technologies
18.16.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
